May212013
Is the U.S. Department of Veterans Affairs (VA) Meeting the Pharmaceutical Needs of Veterans? An Examination of the VA National Formulary, Issues of Patient Safety, and Management of the Pharmacy Benefits Program.
Subcommittee on Health | Room 334 Cannon House Office Building Washington, DC
|
09/22/2009
Opening Statements
Witnesses
Panel 1
- Jack Hoadley, Ph.D., Health Policy Institute, Research Professor, Georgetown University, Washington, DC
- Frank R. Lichtenberg, Ph.D., Columbia University, New York, NY, Courtney C. Brown Professor of Business, and Research Associate, National Bureau of Economic Research
- Richard F. Weidman, Vietnam Veterans of America, Executive Director for Policy and Government Affairs
- William Ray Bullman, M.A.M., National Council on Patient Information and Education, Executive Vice President, Bethesda, MD
Panel 2
- Solomon Iyasu, M.D., MPH, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Director, Division of Epidemiology, Food and Drug Administration, U.S. Department of Health and Human Services
- Belinda J. Finn, Office of Inspector General, Assistant Inspector General for Audits and Evaluations, U.S. Department of Veterans Affairs
- Accompanied By:
- Irene Barnett, Ph.D., Office of Inspector General, U.S. Department of Veterans Affairs, Audit Manager, Bedford Office for Audits and Evaluations
Panel 3
- Michael A. Valentino, R.Ph., MHSA, Veterans Health Administration, U.S. Department of Veterans Affairs, Chief Consultant, Pharmacy Benefits Management Services
- Accompanied By:
- Chester B. Good, M.D., MPH, Veterans Health Administration U.S. Department of Veterans Affairs, Chair, Veterans Affairs Medical Advisory Panel
- Paul Tibbits, M.D., Office of Information and Technology, U.S. Department of Veterans Affairs, Deputy Chief Information Officer for Enterprise Development
Sign Up for Committee Updates
Stay connected with the Committee